Short answer
SHOULDER INNOVATIONS, INC. (SI) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter financial results for period ended September 30, 2026 announced.
SHOULDER INNOVATIONS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter financial results for period ended September 30, 2026 announced
- Press release contains the company’s reported results and management commentary
- Investors should review Exhibit 99.1 for revenue, profitability, cash flow and outlook details
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $16.2M, up 38%, with implant systems sold up approximately 34% to 2,126
- Gross margin expanded to 78.5% from 76.2%, while average selling price increased 2% to $7,616
- Adjusted EBITDA loss improved to $5.5M from $7.5M, despite R&D expense rising 107% to $3.2M
- Full-year 2026 revenue guidance raised to $68M-$70M, implying approximately 44%-48% growth
- Cash, cash equivalents and marketable securities totaled $92.3M at September 30, 2026, supporting continued commercial and product investment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SHOULDER INNOVATIONS, INC. 8-K filings
Get the next SI 8-K as it lands
Follow SI for push alerts, or ask the research agent what this filing means.